Works matching IS 14363291 AND DT 2018 AND VI 21 AND IP 6


Results: 21
    1
    2
    3

    SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signaling.

    Published in:
    Gastric Cancer, 2018, v. 21, n. 6, p. 968, doi. 10.1007/s10120-018-0822-1
    By:
    • Sugase, Takahito;
    • Takahashi, Tsuyoshi;
    • Serada, Satoshi;
    • Fujimoto, Minoru;
    • Ohkawara, Tomoharu;
    • Hiramatsu, Kosuke;
    • Nishida, Toshirou;
    • Hirota, Seiichi;
    • Saito, Yurina;
    • Tanaka, Koji;
    • Miyazaki, Yasuhiro;
    • Makino, Tomoki;
    • Kurokawa, Yukinori;
    • Yamasaki, Makoto;
    • Nakajima, Kiyokazu;
    • Hanasaki, Kazuhiro;
    • Kishimoto, Tadamitsu;
    • Mori, Masaki;
    • Doki, Yuichiro;
    • Naka, Tetsuji
    Publication type:
    Article
    4
    5
    6

    Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching.

    Published in:
    Gastric Cancer, 2018, v. 21, n. 6, p. 1004, doi. 10.1007/s10120-018-0832-z
    By:
    • Ikoma, Naruhiko;
    • Das, Prajnan;
    • Hofstetter, Wayne;
    • Ajani, Jaffer A.;
    • Estrella, Jeannelyn S.;
    • Chen, Hsiang-Chun;
    • Wang, Xuemei;
    • Callender, Rashida A.;
    • Zhu, Cong;
    • Roland, Christina L.;
    • Fournier, Keith F.;
    • Cormier, Janice N.;
    • Mansfield, Paul;
    • Badgwell, Brian D.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial.

    Published in:
    Gastric Cancer, 2018, v. 21, n. 6, p. 1014, doi. 10.1007/s10120-018-0817-y
    By:
    • Takahashi, Naoto;
    • Kanda, Mitsuro;
    • Yoshikawa, Takaki;
    • Takiguchi, Nobuhiro;
    • Fujitani, Kazumasa;
    • Miyamoto, Katsufumi;
    • Ito, Yuichi;
    • Takayama, Osamu;
    • Imano, Motohiro;
    • Mitsumori, Norio;
    • Sakamoto, Junichi;
    • Morita, Satoshi;
    • Kodera, Yasuhiro
    Publication type:
    Article
    20

    Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study.

    Published in:
    Gastric Cancer, 2018, v. 21, n. 6, p. 1041, doi. 10.1007/s10120-018-0811-4
    By:
    • Yamaguchi, Kensei;
    • Fujitani, Kazumasa;
    • Nagashima, Fumio;
    • Omuro, Yasushi;
    • Machida, Nozomu;
    • Nishina, Tomohiro;
    • Koue, Toshiko;
    • Tsujimoto, Mika;
    • Maeda, Kaijiro;
    • Satoh, Taroh
    Publication type:
    Article
    21